AVDLAVADEL PHARMACEUTICALS PLC

Nasdaq avadel.com


$ 16.50 $ 0.69 (4.36 %)    

Friday, 10-May-2024 15:59:55 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 16.52
$ 15.86
$ 16.49 x 200
$ 0.00 x 0
$ 15.86 - $ 17.08
$ 14.77 - $ 19.09
1,889,582
na
1.59B
$ 0.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-16-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-28-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-27

HC Wainwright & Co. analyst Oren Livnat maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the price t...

 craig-hallum-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-23

Craig-Hallum analyst Chase Knickerbocker maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the price targ...

 needham-reiterates-buy-on-avadel-pharmaceuticals-maintains-22-price-target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.

 needham-reiterates-buy-on-avadel-pharmaceuticals-maintains-22-price-target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.

 avadel-pharmaceuticals-q1-cash-and-equivalents-888m

Cash, cash equivalents and marketable securities were $88.8 million as of March 31, 2024.

 avadel-pharmaceuticals-q1-2024-gaap-eps-030-misses-021-estimate-revenue-0

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate...

 needham-reiterates-buy-on-avadel-pharmaceuticals-maintains-22-price-target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.

 american-airlines-to-rally-around-42-here-are-10-top-analyst-forecasts-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 craig-hallum-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-22

Craig-Hallum analyst Chase Knickerbocker maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the price targ...

 avadel-pharmaceuticals-analysts-increase-their-forecasts-after-q4-results

Avadel Pharmaceuticals plc (NASDAQ: AVDL) reported better-than-expected fourth-quarter revenue results and also issued a corpo...

 oppenheimer-maintains-outperform-on-avadel-pharmaceuticals-raises-price-target-to-29

Oppenheimer analyst Francois Brisebois maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Outperform and raises the price...

 hc-wainwright--co-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-25

HC Wainwright & Co. analyst Oren Livnat maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the price t...

 piper-sandler-maintains-overweight-on-avadel-pharmaceuticals-raises-price-target-to-23

Piper Sandler analyst David Amsellem maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Overweight and raises the price t...

 needham-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-22

Needham analyst Ami Fadia maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the price target from $20 to ...

Core News & Articles

Avadel Pharmaceuticals plc (NASDAQ:AVDL), today issued a statement in response to a jury ruling from the United States District...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION